Skip to main content
Cancer Explained
Donate
Beginner 6 min readSource checked

Cervical Cancer Recurrence: What to Ask

Questions to ask when cervical cancer may have come back, including confirmation, scans, biopsy, treatment options, and support.

This is general education — it cannot tell you what to do in your situation.

Instructions and urgent-contact thresholds vary by treatment and care team. If you are in treatment, follow the instructions your oncology team gave you, and contact them about any new or worsening symptom. If you think you may be having a medical emergency, call your local emergency number.

NCI source

NCI PDQ — Cervical Cancer Treatment (Health Professional Version)

A woman greets a smiling clinician at a reception counter
A woman greets a smiling clinician at a reception counter

Key fact

NCI's clinician summary says most recurrences are diagnosed because of new symptoms, and that the usefulness of routine Pap smears and chest x-rays after treatment is unclear.

The short answer

Most cervical cancer recurrences are found because of a symptom, not a routine test. NCI reports recurrence is most likely in the first 2 years, and lists immunotherapy, chemoradiation, palliative drug treatment, exenteration and trials for recurrent disease.

  • NCI's clinician summary says most recurrences are diagnosed because of new symptoms, and that the usefulness of routine Pap smears and chest x-rays after treatment is unclear.

  • Warning signs NCI says you should be asked about are abdominal pain, back pain, a painful or swollen leg, urination problems, cough and fatigue.

  • Recurrence is most likely within the first 2 years, so most guidelines suggest review every 3 to 4 months for 2 years, then every 6 months.

  • Options listed for recurrent or stage IVB disease are immunotherapy, radiation with chemotherapy, palliative systemic therapy, pelvic exenteration and early-phase trials; immunotherapy is the one NCI credits with prolonged disease-free survival.

Choose how you want to understand this

The full explanation.

How a cervical cancer recurrence usually turns up

Most recurrences are found because of a new symptom, not because of a routine test. The NCI professional summary says exactly that, and adds that the value of routine Pap smears and chest x-rays after treatment is unclear.

So the symptom review at each visit is the real screening test. The NCI page lists what you will be asked about: pain in the abdomen or back, a painful or swollen leg, trouble passing urine, a cough, and fatigue.

Imaging leans towards checking a finding rather than fishing. The same summary says scans are used to look into something that has already turned up. That is the general slant, not a ban: stage, what treatment you had, and any new symptom can all put a scan on the calendar, so ask what triggers one for you.

The follow-up rhythm most guidelines use

High-quality studies on follow-up are lacking, and NCI says the best schedule is not known. What it does report is that recurrence is most likely in the first two years.

Because of that, most guidelines suggest a visit every three to four months for two years, then every six months. Your own schedule may differ, and it is fair to ask why.

If it comes back in the middle of the pelvis

Pelvic exenteration is on the NCI list of options for recurrent cervical cancer. It is a very large operation.

NCI's patient summary sets out what it removes. The lower colon, the rectum and the bladder. Also the cervix, the vagina, the ovaries and nearby lymph nodes. Stomas are made so urine and stool can drain into a bag. Surgery to build a new vagina may follow.

The clinician summary gives the other side. In selected people with disease that has come back in the pelvis, 5-year survival runs from 32% to 62%. Ask what it would mean for your bladder, your bowel and your day-to-day life before anything is scheduled.

If the spread is beyond the pelvis

For recurrent or stage IVB disease, NCI lists immunotherapy, radiation with chemotherapy, drug treatment for symptom control, exenteration, and early-phase trials.

Immunotherapy is the one NCI singles out for longer disease-free time. Pembrolizumab on its own was approved for recurrent or spreading cervical cancer whose tumour is PD-L1 positive, meaning a combined positive score of 1 or higher. That is one indication rather than the whole picture: pembrolizumab is also approved in combination with chemotherapy, and other drugs including antibody-drug conjugates have been approved in this setting since. Ask your oncologist which current options your own results and previous treatment open up.

That score comes from a lab test on tumor tissue. Ask whether yours has been done and what the number was.

Questions to write down before the visit

  • Which symptom of mine started this workup?
  • Does anything on my scan need a biopsy to be certain?
  • Where is it back: the middle of the pelvis, the lymph nodes, or further away?
  • Have I already had radiation to that exact area?
  • What is my PD-L1 score, and does it open up immunotherapy?
  • If exenteration is raised, who else should I talk to first?
  • Is a trial open that fits me right now?

Bring someone with you. Ask for the plan written into the visit summary, and ask what would make you call before the next appointment.

When to get help sooner

  • Call 911 or go to an emergency department if vaginal bleeding is heavy enough to soak through pads quickly, or comes with dizziness, faintness or a racing heart. Heavy bleeding is a recognised complication of advanced and recurrent cervical cancer.
  • Call your care team without delay, at any hour, if your temperature reaches 100.4°F (38°C) or higher and your treatment for the recurrence includes chemotherapy, on its own or alongside radiation. That is CDC's threshold for infection during cancer treatment, and chemotherapy strips out the white cells that hold an infection back. It is a medical emergency. If you cannot get through quickly, go to an emergency department and tell them at once that you are on chemotherapy.
  • Call your care team the same day if you pass little or no urine, or you have pain in one side of your back near the ribs. A recurrence in the pelvis can block a ureter and damage the kidney. Call the same day if urine or stool starts leaking from the vagina, which is a fistula. If you are having surgery or radiation with no chemotherapy, that same temperature is a same-day call too.
  • Call your care team within a day or two if one leg becomes newly swollen, or both legs swell, or pelvic or lower back pain keeps building, or discharge turns foul-smelling.

Cancer Staging and Biomarker Testing explain the terms that come up most when cervical cancer comes back. Clinical Trial vs Standard Treatment, Palliative Care, and Questions to Ask Your Doctor cover the decisions that follow a cervical cancer recurrence.

Where this comes from

These questions were drawn from current patient guidance for cervical cancer:

Words to know

Tap any term to see what it means.

Browse the full glossary →

An illustration: pink cancer cells surrounded by blue immune cells

Common questions

How is a cervical cancer recurrence usually picked up?

Usually by a symptom. NCI's clinician summary says most recurrences are diagnosed because of new symptoms and signs, and that the usefulness of routine testing such as a Pap smear and chest x-ray is unclear. Imaging is meant to be used to evaluate a finding rather than as routine screening.

How often should I be seen after treatment?

NCI says high-quality studies are lacking and the best schedule is not known, but that recurrence is most likely within the first 2 years. On that basis most guidelines suggest follow-up every 3 to 4 months for the first 2 years, then every 6 months. It is fair to ask why your own schedule differs.

What is pelvic exenteration?

NCI's patient summary describes total pelvic exenteration as removing the lower colon, rectum and bladder along with the cervix, vagina, ovaries and nearby lymph nodes, with stomas made for urine and stool. NCI's clinician summary reports 5-year survival of 32% to 62% in selected patients with locally recurrent disease.

Could immunotherapy be an option?

Possibly. The FDA approved pembrolizumab for recurrent or metastatic cervical cancer whose tumor expresses PD-L1 with a combined positive score of 1 or higher. That score comes from a laboratory test on tumour tissue, so ask whether yours has been tested and what the result was. It is not the only door: pembrolizumab is also approved combined with chemotherapy, and newer drugs have been approved for this setting, so a low score does not end the conversation.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Your next step

Turn this topic into questions for your next appointment.

Build a question list
Human Connection Layer

Speak With Trained Specialists & Human Navigators

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.

Help Us Improve This Guide

Did this explanation answer your question and help you determine your next step?

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Sources last checked: 2026-08-13 what this meansLast updated: 2026-08-20Next planned review: 2028-07-30

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Source checked This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.